HTR1A and drug-induced dyskinesia: The present study used a rat model of L-DOPA-induced dyskinesia to investigate the effects of vilazodone, an SSRI/5-HT1A receptor partial agonist, on L-DOPA-induced changes in gene regulation in striatal projection neurons and behavior.